These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 13687795)

  • 21. The effect of Monase in depressive states: a multi-blind pilot study.
    AZIMA H; ARTHURS D; SILVER A
    Am J Psychiatry; 1961 May; 117():1029-30. PubMed ID: 13685431
    [No Abstract]   [Full Text] [Related]  

  • 22. Current trends in the use of monoamine oxidase inhibitors in depression.
    PRANGE AJ
    N C Med J; 1960 Dec; 21():546-7. PubMed ID: 13737718
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of monoamino oxidase inhibitor (MOI) in depression. Psychodynamics and biological reactivity].
    CAZULLO CL
    Wien Med Wochenschr; 1960 Sep; 110():731-3. PubMed ID: 13691798
    [No Abstract]   [Full Text] [Related]  

  • 24. Nialamide: clinical and toxicologic study.
    HOLLISTER LE; MOTZENBECKER FP; PRUSMACK JJ
    J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1960; 21():212-6. PubMed ID: 13715374
    [No Abstract]   [Full Text] [Related]  

  • 25. Some pharmacological aspects of monoamine oxidase regulators.
    HORITA A
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():141-5. PubMed ID: 13715853
    [No Abstract]   [Full Text] [Related]  

  • 26. [Monoamine oxidase inhibitors in the treatment of depressive states].
    GARRONE G; DICK P
    Psychiatr Neurol (Basel); 1960 Jul; 140():107-14. PubMed ID: 13703760
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the preparation Ro 4-1038 (monoamine oxidase inhibitor)].
    REITER PJ
    Psychiatr Neurol (Basel); 1960 Jul; 140():143-7. PubMed ID: 13740696
    [No Abstract]   [Full Text] [Related]  

  • 28. [1-Benzyl-1,2,5-methyl-3-isoxazolylcarbonylhydrazine, a monoaminooxidase inhibitor, in the treatment of 84 depressed patients].
    DE LA FUENTE MUNIZ R; FONCERRADA M; MARTINEZ CID E
    Rev Invest Clin; 1960; 12():591-604. PubMed ID: 13720580
    [No Abstract]   [Full Text] [Related]  

  • 29. Psychic energizers in the depressed patient.
    SENSEMAN LA
    R I Med J; 1961 Apr; 44():217-9. PubMed ID: 13750119
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some results of the treatment of depressive states by a monoamine oxidase-inhibiting hydrazide, nialamide].
    FOURNY L; SEGAL J; SEGAL A
    Toulouse Med; 1961 Feb; 62():137-41. PubMed ID: 13701049
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of nialamide and ethyl alcohol on some personality, cognitive and psychomotor variables in normal volunteers.
    CAIRD WK; SLOANE RB; INGLIS J
    J Neuropsychiatr; 1960; 2():31-4. PubMed ID: 13689836
    [No Abstract]   [Full Text] [Related]  

  • 32. A preliminary report on MAO inhibition and clincial effectiveness in the treatment of depressed patients with phenelzine.
    FELDSTEIN A; HOAGLAND H; RIVIERA MR; FREEMAN H
    J Neuropsychiatr; 1960; 2():12-4. PubMed ID: 13698729
    [No Abstract]   [Full Text] [Related]  

  • 33. [On incompatibility between monoamine oxidase inhibitors and imipramin (with remarks on the work of O. Eichhorn "Remarks on psychopharmacological combined therapy" in Wien. Med. Wschr. 111, 1961, 307)].
    HARRER G
    Wien Med Wochenschr; 1961 Aug; 111():551-3. PubMed ID: 13711697
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicologic effects of etryptamine in experimental animals.
    GRAY JE
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():163-5. PubMed ID: 13708060
    [No Abstract]   [Full Text] [Related]  

  • 35. The pharmacology of etryptamine.
    GREIG ME; SEAY PH; FREYBURGER WA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():131-5. PubMed ID: 13708442
    [No Abstract]   [Full Text] [Related]  

  • 36. Experiments with alpha-methyltryptamine.
    HIMWICH HE
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():136-40. PubMed ID: 13714418
    [No Abstract]   [Full Text] [Related]  

  • 37. [The Multidisciplinary Guideline for Depression: a commentary].
    Spijker J; Huyser J; Blom MB
    Tijdschr Psychiatr; 2006; 48(12):921-5. PubMed ID: 17171604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjunctive antidepressant treatment with quetiapine in agitated depression: positive effects on symptom reduction, psychopathology and remission rates.
    Dannlowski U; Baune BT; Böckermann I; Domschke K; Evers S; Arolt V; Hetzel G; Rothermundt M
    Hum Psychopharmacol; 2008 Oct; 23(7):587-93. PubMed ID: 18663773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression: therapy or medication? Therapy and antidepressants may affect the brain differently, but both are effective.
    Roy-Byrne PP
    Health News; 2004 Mar; 10(3):14-5. PubMed ID: 15017943
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjunctive use of antidepressants in a variety of medical problems.
    BATTERMAN RC
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():86-7. PubMed ID: 13687795
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.